Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T00:10:29.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study record content and signaling restricted access to the record. The site chrome (header and navigation) remains visible as part of the error screen.
    Difference
    26%
    Check dated 2026-09-22T23:21:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision history was updated to include new revision metadata (e.g., Revision: v3.7.0 with September 2026 dates) and to remove older revision notes (e.g., v3.6.6) from the current change set.
    Difference
    0.2%
    Check dated 2026-09-15T23:24:21.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-09-01T18:13:00.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a small backend/template update to the Study Details page.
    Difference
    0.0%
    Check dated 2026-08-11T19:54:41.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the template or formatting rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-21T12:58:59.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.